[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30708-30709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10892]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0052; NIOSH-337]


Advisory Board on Radiation and Worker Health, Subcommittee on 
Dose Reconstruction Review (SDRR) Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Subcommittee for Dose 
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and 
Worker Health (ABRWH). This meeting is open to the public, but without 
an oral public comment period. The public is welcome to submit written 
comments in advance of the meeting, per the instructions provided in 
the address section below. Written comments received in advance of the 
meeting will be included in the official record of the meeting. The 
public is also welcome to listen to the meeting by joining the audio 
conference (information below). The audio conference line has 150 ports 
for callers.

DATES: The meeting will be held on July 29, 2020, 10:30 a.m. to 4:00 
p.m., EDT.
    Written comments must be received on or before July 24, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0052; NIOSH-337; NIOSH by any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: National Institute for Occupational Safety and 
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, 
Ohio 45226-1998.
    Instructions: All information received in response to this notice 
must include the agency name and docket number [CDC-2020-0052; NIOSH-
337]. All relevant comments received will be posted without change to 
http://www.regulations.gov, including any personal information 
provided. Instructions: All submissions received must include the 
Agency name and Docket Number. All relevant comments received in 
conformance with the https://www.regulations.gov suitability policy 
will be posted without change to https://www.regulations.gov, including 
any personal information provided. For access to the docket to read 
background documents or comments received, go to https://www.regulations.gov.
    Meeting Information: Audio Conference Call via FTS Conferencing. 
The USA toll-free dial-in number is 1-866-659-0537; the pass code is 
9933701.

FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated 
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24, 
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email [email protected].

SUPPLEMENTARY INFORMATION: 

[[Page 30709]]

    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines that have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule; advice on methods of dose reconstruction, which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and rechartered under Executive Order 
13889 on March 22, 2020, and will terminate on March 22, 2022.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. SDRR was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction.
    Matters to be Considered: The agenda will include discussions on 
the following dose reconstruction program quality management and 
assurance activities: Dose reconstruction cases under review from Set 
27, possibly including cases involving, Amchitka Island Nuclear 
Explosion Site, Argonne National Laboratory, Fee Materials Production 
Centers (``Fernald Plant''), General Electric--Vallecitos, Hanford, 
Idaho National Laboratory, Lawrence Berkeley National Laboratory, 
Lawrence Livermore National Laboratory, Nevada Test Site, Oak Ridge 
Gaseous Diffusion Plant (``K-25''), Office of Science and Technology 
Information (``OSTI''), Paducah Gaseous Diffusion Plant, Portsmouth 
Gaseous Diffusion Plant, Savannah River Site, Y-12, and potentially 
other Department of Energy and Atomic Weapons Employers facilities. 
Agenda items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10892 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P